You just read:

BioMarin Announces Closing of Exercise by Initial Purchasers of Option to Purchase an Additional $50 million of 1.25% Senior Subordinated Convertible Notes due 2027

News provided by

BioMarin Pharmaceutical Inc.

May 19, 2020, 16:15 ET